EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company.
The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.
